Plasma-equivalent glucose at the point-of-care: evaluation of Roche Accu-Chek Inform® and Abbott Precision PCx® glucose meters

Clinica Chimica Acta

Volumn 386, Issue 1-2, 2007, Pages 63-68

  Ghys, Timothy ^a   Goedhuys, Wim ^a   Spincemaille, Katrien ^a   Gorus, Frans ^a   Gerlo, Erik ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Glucometer; Performance; Plasma equivalent glucose; Point of care

Indexed keywords

MALTOSE;

ACCURACY; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL LABORATORY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HUMAN; INSTRUMENTATION; MALE; MEASUREMENT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RELIABILITY;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; DIAGNOSTIC EQUIPMENT; HUMANS; MALTOSE; POINT-OF-CARE SYSTEMS; QUALITY CONTROL; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 34548680752     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.07.025     Document Type: Article

References (37)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329 (1993) 977-986
2. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
3. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
4. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 (2006) 449-461
5. Goldstein D.E., Little R.R., Lorenz R.A., Malone J.I., Nathan D.M., and Peterson C.M. Tests of glycemia in diabetes. Diabetes Care 26 Suppl. 1 (2003) S106-S108
6. Burrin J.M., and Alberti K.G. What is blood glucose: can it be measured?. Diabet Med 7 (1990) 199-206
7. Haeckel R., Brinck U., Colic D., et al. Comparability of blood glucose concentrations measured in different sample systems for detecting glucose intolerance. Clin Chem 48 (2002) 936-939
8. D'Orazio P., Burnett R.W., Fogh-Andersen N., et al. Approved IFCC recommendation on reporting results for blood glucose (abbreviated). Clin Chem 51 (2005) 1573-1576
9. Burnett R.W., D'Orazio P., Fogh-Andersen N., et al. IFCC recommendation on reporting results for blood glucose. Clin Chim Acta 307 (2001) 205-209
10. Flore K., and Delanghe J. Icodextrin: a major problem for glucose dehydrogenase-based glucose point of care testing systems. Acta Clin Belg 61 (2006) 351-354
11. Oyibo S.O., Pritchard G.M., McLay L., et al. Blood glucose overestimation in diabetic patients on continuous ambulatory peritoneal dialysis for end-stage renal disease. Diabet Med 19 (2002) 693-696
12. Davies D.S. Kinetics of icodextrin. Perit Dial Int 14 Suppl. 2 (1994) S45-S50
13. Apperloo J.J., and Vader H.L. A quantitative appraisal of interference by icodextrin metabolites in point-of-care glucose analyses. Clin Chem Lab Med 43 (2005) 314-318
14. Meex C., Poncin J., Chapelle J.P., and Cavalier E. Analytical validation of the new plasma calibrated Accu-Chek Test Strips (Roche Diagnostics). Clin Chem Lab Med 44 (2006) 1376-1378
15. Curme H.G., Columbus R.L., Dappen G.M., et al. Multilayer film elements for clinical analysis: general concepts. Clin Chem 24 (1978) 1335-1342
16. CLSI. Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline. Second Edition (2004), CLSI, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA CLSI document EP5-A2 (ISBN 1-56238-542-9)
17. CLSI. Point-of-Care Blood Glucose Testing in Acute and Chronic Care Facilities; Approved Guideline. Second Edition (2002), CLSI, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA CLSI document C30-A2 (ISBN 1-56238-471-6)
18. CLSI. Procedures and Devices for the Collection of Diagnostic Capillary Blood Specimens; Approved Standard. Fifth Edition (2004), CLSI, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2004 CLSI document H4-A5 (ISBN 1-56238-538-0)
19. Clarke W.L., Cox D., Gonder-Frederick L.A., Carter W., and Pohl S.L. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 10 (1987) 622-628
20. Dixon W.J. Processing data for outliers. Biometrics 9 (1983) 74-89
21. CLSI. Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline. Second Edition (2002), CLSI, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA CLSI document EP9-A2 (ISBN 1-56238-472-4)
22. Larsson-Cohn U. Differences between capillary and venous blood glucose during oral glucose tolerance tests. Scand J Clin Lab Invest 36 (1976) 805-808
23. American Diabetes Association. Consensus statement on self-monitoring of blood glucose. Diabetes Care 10 (1987) 93-99
24. American Diabetes Association. Self-monitoring of blood glucose. Diabetes Care 17 (1994) 81-86
25. American Diabetes Association. Self-monitoring of blood glucose. Diabetes Care 19 Suppl. 1 (1996) S62-S66
26. Novis D.A., and Jones B.A. Interinstitutional comparison of bedside blood glucose monitoring program characteristics, accuracy performance, and quality control documentation: a College of American Pathologists Q-Probes study of bedside blood glucose monitoring performed in 226 small hospitals. Arch Pathol Lab Med 122 (1998) 495-502
27. Chance J.J., Li D.J., Jones K.A., Dyer K.L., and Nichols J.H. Technical evaluation of five glucose meters with data management capabilities. Am J Clin Pathol 111 (1999) 547-556
28. Savoca R., Jaworek B., and Huber A.R. New "plasma referenced" POCT glucose monitoring systems-are they suitable for glucose monitoring and diagnosis of diabetes?. Clin Chim Acta 372 (2006) 199-201
29. Kimberly M.M., Vesper H.W., Caudill S.P., et al. Variability among five over-the-counter blood glucose monitors. Clin Chim Acta 364 (2006) 292-297
30. Kristensen G.B., Christensen N.G., Thue G., and Sandberg S. Between-lot variation in external quality assessment of glucose: clinical importance and effect on participant performance evaluation. Clin Chem 51 (2005) 1632-1636
31. Tang Z., Lee J.H., Louie R.F., and Kost G.J. Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing. Arch Pathol Lab Med 124 (2000) 1135-1140
32. Soldin S.J., Devairakkam P.D., and Aagarwalla P.K. Evaluation of the Abbott PCx (R) point of care glucose analyzer in a pediatric hospital. Clin Biochem 33 (2000) 319-321
33. Janssen W., Harff G., Caers M., and Schellekens A. Positive interference of icodextrin metabolites in some enzymatic glucose methods. Clin Chem 44 (1998) 2379-2380
34. U.S. Food and Drug Administration. FDA reminders for falsely elevated glucose readings from inappropriate test method. http://www.fda.gov/cdrh/oivd/news/glucosefalse.html (accessed 18/07/2007)
35. Falsely elevated glucose readings from use of inappropriate test method: FDA offers guidance. J Clin Eng 31 (2006) 14-15
36. Wang R., Skoufos L., and Martis L. Glucose monitoring for diabetic patients using icodextrin. Perit Dial Int 24 (2004) 296-297
37. Wens R., Taminne M., Devriendt J., et al. A previously undescribed side effect of icodextrin: overestimation of glycemia by glucose analyzer. Perit Dial Int 18 (1998) 603-609